Shares of Emcure Pharmaceuticals rose 2.99% to Rs 1,836.50 on Monday after Motilal Oswal initiated coverage on the stock with a Buy rating and a target price of Rs 2,260, implying a potential upside of 23% from the current market price.Motilal Oswal said, "Emcure is implementing efforts to enhance differentiated offerings to both DF and international markets through its own R&D and acquired produc...

The benchmark indices closed flat after a range-bound trading session on July 16, with weakness in market breadth. About 1,673 shares declined, compared to 1,307 advancing shares on the NSE. The market is expected to trade within the previous week's range, and a decisive breakout on either side is needed for a firm directional move going forward. Below are some short-term trading ideas to consider...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and appointments, here’s a quick look at which stocks will be in focus in today's trade:Quarterly Business UpdatePunjab & Sind Bank Q1 (YoY)Total business grows 15.33% to Rs 2.67 lakh crore Vs Rs 2.31 lakh croreTotal deposits increase 12.16% to Rs 1.47 lakh crore ...

Equity benchmarks extended their northward journey for the fifth consecutive session, rising by one-third of a percent on June 18 amid supportive market breadth. About 1,713 shares advanced, compared to 1,291 declining shares on the NSE. The market may give up some gains due to profit booking after the five-day rally. However, the overall trend remains positive. Below are some short-term trading i...

Equity benchmarks witnessed a 1 percent correction on June 8 amid weak global cues, with bears dominating market breadth. Around 2,411 shares came under selling pressure compared to 579 advancing stocks on the NSE. Following the sharp sell-off, the market is expected to consolidate and trade in a range-bound manner. Below are some short-term trading ideas to consider:Jigar S Patel, Senior Manager ...